# IRulya Therapeutics Inc.: Form 8-K, filed Aug 17, 2026

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2026-08-17
- Accepted by EDGAR: Aug 17, 2026, 06:01 ET
- Period: 2026-08-17
- Accession: 0001193125-26-353141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312526353141/d379347d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312526353141/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312526353141/d379347d8k.htm

Filed Aug 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-353141. Last ingested by Listed: Nov 13, 2026, 15:30 ET. No prices; not investment advice.